1. Home
  2. PDSB vs SQNS Comparison

PDSB vs SQNS Comparison

Compare PDSB & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • SQNS
  • Stock Information
  • Founded
  • PDSB 2005
  • SQNS 2003
  • Country
  • PDSB United States
  • SQNS France
  • Employees
  • PDSB N/A
  • SQNS N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • SQNS Semiconductors
  • Sector
  • PDSB Health Care
  • SQNS Technology
  • Exchange
  • PDSB Nasdaq
  • SQNS Nasdaq
  • Market Cap
  • PDSB 43.1M
  • SQNS 37.8M
  • IPO Year
  • PDSB N/A
  • SQNS 2011
  • Fundamental
  • Price
  • PDSB $1.58
  • SQNS $1.80
  • Analyst Decision
  • PDSB Strong Buy
  • SQNS Strong Buy
  • Analyst Count
  • PDSB 2
  • SQNS 1
  • Target Price
  • PDSB $10.00
  • SQNS $7.50
  • AVG Volume (30 Days)
  • PDSB 636.9K
  • SQNS 97.7K
  • Earning Date
  • PDSB 05-14-2025
  • SQNS 05-06-2025
  • Dividend Yield
  • PDSB N/A
  • SQNS N/A
  • EPS Growth
  • PDSB N/A
  • SQNS N/A
  • EPS
  • PDSB N/A
  • SQNS 2.16
  • Revenue
  • PDSB N/A
  • SQNS $38,858,000.00
  • Revenue This Year
  • PDSB N/A
  • SQNS N/A
  • Revenue Next Year
  • PDSB N/A
  • SQNS $93.87
  • P/E Ratio
  • PDSB N/A
  • SQNS $0.83
  • Revenue Growth
  • PDSB N/A
  • SQNS 40.06
  • 52 Week Low
  • PDSB $0.85
  • SQNS $0.95
  • 52 Week High
  • PDSB $4.42
  • SQNS $4.28
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 66.13
  • SQNS 46.76
  • Support Level
  • PDSB $1.24
  • SQNS $1.50
  • Resistance Level
  • PDSB $1.66
  • SQNS $1.97
  • Average True Range (ATR)
  • PDSB 0.11
  • SQNS 0.15
  • MACD
  • PDSB 0.03
  • SQNS 0.03
  • Stochastic Oscillator
  • PDSB 69.42
  • SQNS 60.87

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

Share on Social Networks: